Abstract:Primary ovarian insufficiency (POI) is determined by exhaustion of follicles in the ovaries, which leads to infertility before the age of 40 years. It is characterized by a strong familial and heterogeneous genetic background. Therefore, we will mainly discuss the genetic basis of POI in this review. We identified 107 genes related to POI etiology in mammals described by several independent groups. Thirty-four of these genes (AARS2, AIRE, ANTXR1, ATM, BMPR1B, CLPP, CYP17A1, CYP19A1, DCAF17, EIF2B, ERAL1, FANCA, FANCC, FMR1, FOXL2, GALT, GNAS, HARS2, HSD17B4, LARS2, LMNA, MGME1, NBN, PMM2, POLG, PREPL, RCBTB1, RECQL2/3/4, STAR, TWNK, and XRCC4/9) have been linked to syndromic POI and are mainly implicated in metabolism function and meiosis/DNA repair. In addition, the majority of genes associated with nonsyndromic POI, widely expanded by high-throughput techniques over the last decade, have been implicated in ovarian development and meiosis/DNA repair pathways (ATG7, ATG9, ANKRD31, BMP8B, BMP15, BMPR1A, BMPR1B, BMPR2, BNC1, BRCA2, CPEB1, C14ORF39, DAZL, DIAPH2, DMC1, ERCC6, FANCL, FANCM, FIGLA, FSHR, GATA4, GDF9, GJA4, HELQ, HSF2BP, HFM1, INSL3, LHCGR, LHX8, MCM8, MCM9, MEIOB, MSH4, MSH5, NANOS3, NOBOX, NOTCH2, NR5A1, NUP107, PGRMC1, POLR3H, PRDM1, PRDM9, PSMC3IP, SOHLH1, SOHLH2, SPIDR, STAG3, SYCE1, TP63, UBR2, WDR62, and XRCC2), whereas a few are related to metabolic functions (EIF4ENIF1, KHDRBS1, MRPS22, POLR2C). Some genes, such as STRA8, FOXO3A, KIT, KITL, WNT4, and FANCE, have been shown to cause ovarian insufficiency in rodents, but mutations in these genes have yet to be elucidated in women affected by POI. Lastly, some genes have been rarely implicated in its etiology (AMH, AMHR2, ERRC2, ESR1, INHA, LMN4, POF1B, POU5F1, REC8, SMC1B). Considering the heterogeneous genetic and familial background of this disorder, we hope that an overview of literature data would reinforce that genetic screening of those patients is worthwhile and helpful for better genetic counseling and patient management.

Roles of Meiotic Defects in Pathogenesis of Primary Ovarian Insufficiency

An Update on Primary Ovarian Insufficiency

Physiological and pathological mechanisms of oocyte meiosis.

Pathogenic variants of meiotic double strand break (DSB) formation genes PRDM9 and ANKRD31 in premature ovarian insufficiency

Genetic insights into the complexity of premature ovarian insufficiency

Genetics of ovarian insufficiency and defects of folliculogenesis

BRCA2 Deficiency is a Potential Driver for Human Primary Ovarian Insufficiency

Landscape of pathogenic mutations in premature ovarian insufficiency

X chromosome rearrangement associated with premature ovarian insufficiency as diagnosed by molecular cytogenetic methods: a case report and review of the literature

Meiotic maturation failure in primary ovarian insufficiency: insights from a bovine model

Gene mutations impede oocyte maturation, fertilization, and early embryonic development

Identification and Characterization of Novel Compound Heterozygous Variants in FSHR Causing Primary Ovarian Insufficiency with Resistant Ovary Syndrome.

DNA double-strand break genetic variants in patients with premature ovarian insufficiency

Meiotic Defects in Human Oocytes: Potential Causes and Clinical Implications

The Molecular Regulatory Mechanisms of Meiotic Arrest and Resumption in Oocyte Development and Maturation

Searching for the 'X' factor: investigating the genetics of primary ovarian insufficiency

Basonuclin 1 Deficiency is a Cause of Primary Ovarian Insufficiency.

Primary ovarian insufficiency: update on clinical and genetic findings

Haploinsufficiency in Non-Homologous End Joining Factor 1 Induces Ovarian Dysfunction in Humans and Mice.

Polycomb Repressive Complex 1 Modulates Granulosa Cell Proliferation in Early Folliculogenesis to Support Female Reproduction.

Identifying therapeutic targets for primary ovarian insufficiency through integrated genomic analyses